Skin Care Regimen for Improving Photoaging Signs on the Face

Part of paid clinical trials in San Diego, California.

Sponsor
Goldman, Butterwick, Fitzpatrick and Groff
Study ID
NCT06603857
Phase
PHASE2/PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Improve Photoaging Signs

Eligibility Criteria

Sex
ALL
Age
30 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • CE Ferulic — DRUG
    CE Ferulic serum regimen combined with laser treatment
  • Sham Comparator — DRUG
    Vehicle serum regimen combined with laser treatment
  • 1927nm (Clear and Brilliant Perméa®) — DEVICE
    non-ablative fractional diode laser

Study Details

Compare the effectiveness of laser treatment using CE Ferulic versus vehicle pre/post laser.

Key Dates

Start date
Sep 27, 2024
Status verified
Sep 2024
Primary completion
Dec 31, 2024
Completion
Feb 28, 2025

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: Group A
    Subjects who will receive two treatments with 1927nm (Clear and Brilliant Perméa®) non-ablative fractional diode laser for rejuvenation of photodamaged skin of the face in pairing with Skinceuticals CE Ferulic
  • Sham Comparator: Group B
    Subjects who will receive two treatments with 1927nm (Clear and Brilliant Perméa®) non-ablative fractional diode laser for rejuvenation of photodamaged skin of the face in pairing with vehicle serum

Primary Outcome Measure

Global Fine Lines [ Time Frame: Screening, Baseline, Day 28, Day 56, Day 84 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Dermatology Research CenterSan DiegoCalifornia92121-

Find similar trials in San Diego, CA